Sponsored Events


Contract-Biotechnology.com is routinely participating in international partnering and conferences. The following event are sponsored by Contract-Biotechnology.com



Join Oxford Global’s 5th Annual Drug Discovery USA Congress taking place on the 11-12 October 2018 in San Diego. Across the two days, over 40 expert speakers will provide you with insights into the latest technological innovations and strategic approaches in drug discovery and drug chemistry. View Agenda: https://bit.ly/2MIXuM8

The American biopharmaceutical research sector has been a world leader in the development of new medicines over the past 30 years and it continues to drive biopharmaceutical innovation. Our conference delivers an extensive look across the development process: from drug discovery innovation and strategies to computational chemistry and informatics for drug design.The conference will feature over 40 presentations from leading heads of the pharmaceutical industry and ensures you will benefit from the latest case studies and high level scientific debate. Topic discussion ranges across the latest validation and optimisation strategies in neuroscience, cardiology and oncology. Further talks look at approaches to phenotypic and genomic drug discovery design, as well as novel approaches to drug design: AI-based design, DNA Encoded Libraries and protein-protein interactions.Include 4 Streams:

  • Day 1 Stream 1: Drug Discovery Innovation and Strategies
  • Day 2 Stream 1: Phenotypic and Genomic Drug Discovery
  • Day 1 Stream 2: Computational Chemistry and Informatics for Drug Discovery
  • Day 2 Stream 2:
    • Part 1: Novel Approaches to Drug Design
    • Part 2: DNA Encoded Libraries
 For more information contact g.alonso@oxfordglobal.co.uk or join the congress conversation on Twitter @DrugDiscoveryUS  or our LinkedIn Group: Drug Discovery & Development Network



Orphan Drugs and Rare Diseases Conference 17 – 18 October 2018 London, UK http://www.orphandrugs.co.uk/contrbioWL

SMi’s Orphan Drugs and Rare Diseases Conference bringing together regulatory agencies, pharmaceutical companies, non-profit organisations and orphan drugs developers to construct an agenda that addresses the driving economic factors, policies and issues that will affect the development of orphan drugs globally including commercialisation, policies, reimbursement, and pricing. Discuss the pricing and reimbursement of orphan drugs; Understand the challenges of patient recruitment and patient-centric research; Hear the MHRA’s perspective on benefit-risk assessment in rare diseases; Explore the clinical development of orphan drugs for rare disease; Gain insight into potential synergies between regulators and assessors. Amongst speakers: Carina Schey - University of Groningen; Xavier Ortega – Minoryx; Nigel Nicholls - BioMarin Europe; Yolanda Barbachano – MHRA; Michale Bouskila-Chubb – Healx and many others! Post-conference workshop (19 October) on Working together for HTA in rare diseases - a step too far or the way forward?

Further details at http://www.orphandrugs.co.uk/contrbioWL  #smiorphandrugs CONTACT:+44 (0)20 7827 6000 ldurneva@smi-online.co.uk


SMi’s 5th Annual Biosimilars USA , 14th - 15th November 2018 New Jersey, USA


Building on the success of previous events, SMi proudly announces the return of its 5th Annual Biosimilars USA Conference, taking place in New Jersey on the 14th and 15th November 2018.This fifth annual event will gather a global audience of biosimilar experts and industry-thought leaders to discuss biosimilar manufacturing and commercialization considerations specific to the U.S. Fresh from the press: On March 7th, 2018, the U.S.-FDA’s Commissioner, Scott Gottlieb, MD, announced that Biosimilar medicines are now a top priority for the FDA. Join us this November to learn how to take advantage of the FDA’s focus on biosimilars, accelerate your biosimilar pipeline and achieve FDA approval. Hear from a selection of carefully handpicked keynote addresses and case studies presented to you by top manufacturing and leading distributors of market approved biosimilars, as they offer a unique insight into the areas of manufacturing, commercialization, device design, uptake, switching, interchangeability, and regulations.

PLUS TWO INTERACTIVE HALF-DAY PRE-CONFERENCE WORKSHOPS.Tuesday 25th September 2018, Copthorne Tara Hotel, Central London, UK.This event is CPD accredited. #SMiBioSimUSA

International Neurology Conference is going to be held during December 03-05, 2018, Valencia, SpainNeurology-2018 

Participants has a wide choice of selection in the scientific sessions please see the link: https://neurology.madridge.com/themes.php.

Neurology-2018 conference includes Plenary lectures, Keynote lectures and short courses by eminent personalities from around the world in addition to contributed papers both oral and poster presentations. Abstract submission: https://neurology.madridge.com/guidelines.php 

 For list Committee: https://neurology.madridge.com/committee.php. For list of presenters: Won-Myong Bahk, The Catholic University of Korea.  Bo-Hyun Yoon, Naju National Hospital, Sang-Yeol Lee, MD, PhD. Department of Psychiatry, College of Medicine, Wonkwang ,University Hospital ,Duk-In Jon, Hallym University, Moon-Doo Kim, Jeju National University,  Kwang Huen Lee, Dongguk UniversityBeomwoo, Konkuk University. Young-Min Park, Inje University College of Medicine.Young-Joon Kwon Soonchunhyang University. Dae-Bo Lee, National Forensic Hospital  Andrew Collins, UCL Institute of Neurology, UK. Min Zhuo Xian Jiaotong University, China Himanshu Agarwal, All India Institute of Medical Sciences, India Miroslava Navratilova, Czech Republic, Fatemeh Ehsani, Semnan University of Medical Sciences, Iran Jun Hwi Cho, Kangwon National University. Elkaoui habiba, University Ibn Tofail, Morocco  Hajar benmhammed, Morocco  Dilshoda Akramova , Tashkent Medical Academy,Eric gueumekane bila lamou, UCAD- Senegal 

The Conference Venue is Confirmed, you can book your accommodation directly at the Venue:Please see: https://neurology.madridge.com/conference-venue


Hotel Medium Valencia

Avenida d'Amado Granell Mesado, 48  

46013 Valencia, Spain  

Tel: +34 96 3347800

Please Note: Hurry to submit abstracts or register to confirm your slots. If you have completed both please ignore.Letter of Invitations will be issued upon request for visa purpose.

Abstract Submission Opens:

January 15, 2018 – November 03, 2018

Earlybird Registration:

February 08, 2018 -  August 27, 2018

Standard Registration:

March 16, 2018 - December 03, 2018


To arrange a meeting, please contact us and we will arrange a mutually convenient time.